225-cm Catheter Length Expands Access Points in Atherectomy Procedures to Help Reduce Access Site Complications and Accelerate Patient RecoveryLATHAM, N.Y.--(BUSINESS...
Patented Advances in Gyrocardiography Bring Affordable, Clinical-Grade Disease Detection to Remote Patients with SmartphonesTURKU, Finland & PALO ALTO, Calif.--(BUSINESS WIRE)--#VC--CardioSignal...
Red Light Holland's natural psilocybin microdosing capsules developed from psilocybin truffles grown in the Company's farm in the Netherlands, have...
DENVER, CO / ACCESSWIRE / January 23, 2024 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company...
CONSHOHOCKEN, PA / ACCESSWIRE / January 23, 2024 / NextEvo Naturals ("NextEvo™" or the "Company"), a premium supplement brand focused...
Peer-reviewed study demonstrates Waymark Signal is 90 percent accurate in predicting avoidable ER and hospital visitsSAN FRANCISCO, CA / ACCESSWIRE...
Company's growing data ecosystem supports the development of large data models for its future predictive technologies and Cardiac AI cloud...
LAS VEGAS, NV / ACCESSWIRE / January 23, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company")a...
Genomate Health Inc, a global leader in precision oncology, announces its strategic partnership with Intelligene Healthcare Pvt Ltd, marking a...
BOULDER, CO / ACCESSWIRE / January 23, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing...
ATLANTA, Jan. 23, 2024 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of...
ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to...
- University of Utah Hospital, Lori Gawron, M.D. of the Obstetrics and Gynecology (OB/GYN) Department, was an instrumental investigator in...
CAMBRIDGE, Mass., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Seemi Khan, M.D., M.P.H., M.B.A., has...
SOLANA BEACH, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling...
HOUSTON, TX, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW) today announced...
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently...
Imugene using MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to support azer-cel – a potential first-in-class allogeneic CD19 CAR T...
REDWOOD CITY, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company committed to developing novel, transformative...
Phase I/II trial assessing the safety and efficacy of RECCE® 327 (R327), a broad-spectrum anti-infective as a topical treatment, met...